Scientists say popular weight loss injections can slow biological aging, attributing the main reason to the improvement of a wide range of diseases in users. Results from several studies on this topic were presented at the European Society of Cardiology conference, showing that semaglutide, sold under the brand names 'Ozempic' and 'Wegovy', has 'broad benefits beyond what was previously thought.' Scientists state that this drug reduces inflammation levels in the body, regardless of whether it aids in weight loss, and can help treat several inflammation-related diseases, including cancer, joint inflammation or arthritis, Alzheimer's, and Parkinson's. A series of trials by researchers from Yale and Harvard University have shown that semaglutide can reverse kidney disease progression, prevent heart failure, reduce previously untreatable high blood pressure, and lower the risk of death from COVID-19 by up to one-third. In these studies, over 17,600 individuals aged 44 and older were monitored. These individuals had excess weight and suffered from cardiovascular diseases but did not have diabetes. Previous studies had shown that this drug also reduces mortality from heart attacks and strokes by up to one-fifth. Semaglutide, marketed as 'Ozempic', is prescribed for the treatment of type 2 diabetes and also for weight control, mimicking the hormone 'GLP-1' that is secreted by the intestine after eating. This hormone performs various functions, including aiding insulin production, slowing gastric emptying, and lowering blood sugar levels. Experts have warned that this drug cannot replace proper nutrition and exercise and should be used under medical supervision. Like any other medication, Ozempic comes with a range of side effects. This report also utilized sources such as 'The Times' and 'BBC World'. The increasing demand for the popular drug 'Ozempic' has led China to produce a similar version. The U.S. Food and Drug Administration has seized counterfeit versions of the weight loss drug 'Ozempic'. The UK is investigating the connection between weight loss and diabetes medications with suicide and self-harm. The popularity of the drug 'Wegovy' for weight loss; American insurers: we do not cover it. What we know about 'Ozempic'; the weight loss drug that has made waves on TikTok.
Results of Several Studies: 'Ozempic' Delays Biological Aging
Recent studies presented at a European conference indicate that the weight loss drug Ozempic (semaglutide) can significantly delay biological aging and improve various health conditions. Researchers from Yale and Harvard found it can reverse kidney disease, prevent heart failure, and reduce COVID-19 mortality risk. This matters as it highlights a potential breakthrough in treating age-related diseases and managing chronic health issues.
👥 Key Players
⚡ Actions
📰 What Happened
Scientists report that 'Ozempic' injections can slow biological aging in users.
- Scientists announce Users of Ozempic
- Researchers from Yale and Harvard University present Medical community
- Experts warn Users of Ozempic
💡 Why It Matters
📚 Background
Ozempic shows potential benefits beyond weight loss, impacting various health conditions.
📝 Key Evidence
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%